146 related articles for article (PubMed ID: 21468926)
1. Antibacterial activities of macrolactin A and 7-O-succinyl macrolactin A from Bacillus polyfermenticus KJS-2 against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.
Kim DH; Kim HK; Kim KM; Kim CK; Jeong MH; Ko CY; Moon KH; Kang JS
Arch Pharm Res; 2011 Jan; 34(1):147-52. PubMed ID: 21468926
[TBL] [Abstract][Full Text] [Related]
2. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.
Franchi D; Climo MW; Wong AH; Edmond MB; Wenzel RP
Clin Infect Dis; 1999 Dec; 29(6):1566-8. PubMed ID: 10585815
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
Wang Z; Cao B; Liu YM; Gu L; Wang C
Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
[TBL] [Abstract][Full Text] [Related]
4. Macrolactin S, a new antibacterial agent with FabG-inhibitory activity from Bacillus sp. AT28.
Sohn MJ; Zheng CJ; Kim WG
J Antibiot (Tokyo); 2008 Nov; 61(11):687-91. PubMed ID: 19168985
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 1.
Bremner JB; Keller PA; Pyne SG; Boyle TP; Brkic Z; David DM; Robertson M; Somphol K; Baylis D; Coates JA; Deadman J; Jeevarajah D; Rhodes DI
Bioorg Med Chem; 2010 Apr; 18(7):2611-20. PubMed ID: 20236828
[TBL] [Abstract][Full Text] [Related]
6. 7-O-malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and a small-colony variant of Burkholderia cepacia.
Romero-Tabarez M; Jansen R; Sylla M; Lünsdorf H; Häussler S; Santosa DA; Timmis KN; Molinari G
Antimicrob Agents Chemother; 2006 May; 50(5):1701-9. PubMed ID: 16641438
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of vancomycin-resistant enterococci and Staphylococcus aureus in the intestinal tracts of hospitalized patients.
Ray AJ; Pultz NJ; Bhalla A; Aron DC; Donskey CJ
Clin Infect Dis; 2003 Oct; 37(7):875-81. PubMed ID: 13130397
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
Bezian MC; Ribou G; Masquelier B
Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of methicillin-resistant Staphylococcus aureus and enterococci to teicoplanin in Pakistan: the MRSET study.
Ahmed A; Hussain S; Ijaz T; Hashemy I
J Pak Med Assoc; 2014 Mar; 64(3):256-9. PubMed ID: 24864595
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activities of hydrophobic 2-arylbenzofurans and an isoflavone against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.
Fukai T; Oku Y; Hano Y; Terada S
Planta Med; 2004 Jul; 70(7):685-7. PubMed ID: 15303263
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of phytochemicals isolated from Erythrina zeyheri against vancomycin-resistant enterococci and their combinations with vancomycin.
Sato M; Tanaka H; Oh-Uchi T; Fukai T; Etoh H; Yamaguchi R
Phytother Res; 2004 Nov; 18(11):906-10. PubMed ID: 15597305
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Garrison MW; Nuemiller JJ
Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci.
Putnam SD; Sader HS; Farrell DJ; Biedenbach DJ; Castanheira M
Int J Antimicrob Agents; 2011 Jan; 37(1):39-45. PubMed ID: 21075602
[TBL] [Abstract][Full Text] [Related]
14. Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection.
Bowker KE; Noel AR; MacGowan AP
J Antimicrob Chemother; 2009 Nov; 64(5):1044-51. PubMed ID: 19759041
[TBL] [Abstract][Full Text] [Related]
15. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
Thamlikitkul V
J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype.
Song JH; Ko KS; Suh JY; Oh WS; Kang CI; Chung DR; Peck KR; Lee NY; Lee WG
J Antimicrob Chemother; 2008 Apr; 61(4):838-44. PubMed ID: 18230690
[TBL] [Abstract][Full Text] [Related]
20. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
Efe S; Sinirtaş M; Ozakin C
Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
